Home › Compare › CTCXW vs BTI

CTCXW vs BTI: Dividend Comparison 2026

CTCXW yields 7490.64% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCXW wins by $3219325239215192.50M in total portfolio value
10 years
CTCXW
CTCXW
● Live price
7490.64%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3219325239215192.50M
Annual income
$3,136,944,464,329,217,000,000.00
Full CTCXW calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — CTCXW vs BTI

📍 CTCXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXWBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCXW + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTCXW pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCXW
Annual income on $10K today (after 15% tax)
$636,704.12/yr
After 10yr DRIP, annual income (after tax)
$2,666,402,794,679,834,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, CTCXW beats the other by $2,666,402,794,679,834,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCXW + BTI for your $10,000?

CTCXW: 50%BTI: 50%
100% BTI50/50100% CTCXW
Portfolio after 10yr
$1609662619607596.25M
Annual income
$1,568,472,232,164,608,400,000.00/yr
Blended yield
97.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

CTCXW
No analyst data
Altman Z
-38.0
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCXW buys
0
BTI buys
0
No recent congressional trades found for CTCXW or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXWBTI
Forward yield7490.64% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$3219325239215192.50M ✓$37.7K
Annual income after 10y$3,136,944,464,329,217,000,000.00 ✓$2,786.64
Total dividends collected$3213812604182292.00M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CTCXW vs BTI ($10,000, DRIP)

YearCTCXW PortfolioCTCXW Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$759,764$749,063.67$11,299$598.92+$748.5K → CTCXW
2$54,000,925$53,187,977.91$12,794$703.91+$53.99M → CTCXW
3$3,590,852,097$3,533,071,107.68$14,518$829.07+$3590.84M → CTCXW
4$223,408,125,107$219,565,913,362.68$16,513$978.64+$223408.11M → CTCXW
5$13,005,862,347,544$12,766,815,653,679.31$18,827$1,157.84+$13005862.33M → CTCXW
6$708,523,022,229,903$694,606,749,518,031.20$21,518$1,373.12+$708523022.21M → CTCXW
7$36,122,824,222,390,480$35,364,704,588,604,476.00$24,657$1,632.46+$36122824222.37M → CTCXW
8$1,723,706,063,164,109,000$1,685,054,641,246,151,400.00$28,329$1,945.74+$1723706063164.08M → CTCXW
9$76,991,378,398,107,710,000$75,147,012,910,522,120,000.00$32,637$2,325.33+$76991378398107.69M → CTCXW
10$3,219,325,239,215,192,500,000$3,136,944,464,329,217,000,000.00$37,708$2,786.64+$3219325239215192.50M → CTCXW

CTCXW vs BTI: Complete Analysis 2026

CTCXW — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCXW Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this CTCXW vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCXW vs SCHDCTCXW vs JEPICTCXW vs OCTCXW vs KOCTCXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.